4//SEC Filing
Huang Alan 4
Accession 0000899243-21-033151
CIK 0001819133other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 7:00 PM ET
Size
5.5 KB
Accession
0000899243-21-033151
Insider Transaction Report
Form 4
Huang Alan
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-08-12+169,859→ 169,859 totalExercise: $9.56Exp: 2031-08-12→ Common Stock (169,859 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a four-year period, at a rate of 25% on August 10, 2022, with the remaining option shares vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Tango Therapeutics, Inc.
CIK 0001819133
Entity typeother
Related Parties
1- filerCIK 0001877364
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 7:00 PM ET
- Size
- 5.5 KB